Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China SXT Pharmaceuticals (SXTC) Construction in Progress (2018 - 2023)

Historic Construction in Progress for China SXT Pharmaceuticals (SXTC) over the last 6 years, with Q1 2023 value amounting to $349390.0.

  • China SXT Pharmaceuticals' Construction in Progress fell 377.0% to $349390.0 in Q1 2023 from the same period last year, while for Mar 2023 it was $349390.0, marking a year-over-year decrease of 377.0%. This contributed to the annual value of $349390.0 for FY2023, which is 377.0% down from last year.
  • Latest data reveals that China SXT Pharmaceuticals reported Construction in Progress of $349390.0 as of Q1 2023, which was down 377.0% from $363078.0 recorded in Q1 2022.
  • In the past 5 years, China SXT Pharmaceuticals' Construction in Progress registered a high of $649235.0 during Q1 2019, and its lowest value of $328372.0 during Q1 2020.
  • Over the past 5 years, China SXT Pharmaceuticals' median Construction in Progress value was $355614.0 (recorded in 2021), while the average stood at $409137.8.
  • Per our database at Business Quant, China SXT Pharmaceuticals' Construction in Progress plummeted by 4942.17% in 2020 and then soared by 829.61% in 2021.
  • Quarter analysis of 5 years shows China SXT Pharmaceuticals' Construction in Progress stood at $649235.0 in 2019, then tumbled by 49.42% to $328372.0 in 2020, then rose by 8.3% to $355614.0 in 2021, then increased by 2.1% to $363078.0 in 2022, then dropped by 3.77% to $349390.0 in 2023.
  • Its Construction in Progress stands at $349390.0 for Q1 2023, versus $363078.0 for Q1 2022 and $355614.0 for Q1 2021.